Estimates GFR and CKD stage (G1-G5) from serum creatinine, age, and sex
Primary source: Inker LA et al. N Engl J Med 2021; 385: 1737-1749. KDIGO 2024 CKD Guideline
CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) is the standard equation for estimating glomerular filtration rate (GFR) from serum creatinine. The 2021 version (Inker LA et al., NEJM 2021) removed the race coefficient, which previously overestimated GFR in Black patients and delayed referral for renal replacement therapy.
The equation uses creatinine, age, and sex. The result is GFR in mL/min/1.73 m². CKD stages per KDIGO 2024: G1 — ≥ 90 (normal or high, with markers of kidney damage); G2 — 60-89 (mildly decreased); G3a — 45-59; G3b — 30-44; G4 — 15-29 (preparation for renal replacement therapy); G5 — < 15 (renal replacement therapy or palliative care).
KDIGO 2024 recommends CKD-EPI 2021 as the standard equation. For borderline results (between G2 and G3a), CKD-EPI cystatin C can be used for confirmation. Risk of CKD progression is stratified using the KDIGO heat map (GFR × albuminuria).
Sex — used as a coefficient in the equation.
68-year-old woman, type 2 diabetes for 12 years, hypertension. Serum creatinine 110 µmol/L. Urine albumin 250 mg/g creatinine.
By CKD-EPI 2021, for a 68-year-old woman with creatinine 110 µmol/L, GFR ≈ 47 mL/min/1.73 m².
GFR 47 plus albuminuria A2 = CKD G3a A2 — high risk of progression on the KDIGO heat map. Management: optimize diabetes control (HbA1c < 7%, start an SGLT2 inhibitor — dapagliflozin or empagliflozin are indicated at GFR ≥ 25), control BP < 130/80 (ACE inhibitor/ARB at the maximum tolerated dose), statin, sodium restriction, caution with NSAIDs and contrast studies. Recheck GFR and albuminuria every 3-6 months. Refer to nephrology.
Validated scores and formulas with full interpretation, clinical examples and source references. Open access, no registration required.
65+ calculators · scores and formulas · interpretation with management notes